These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37075433)

  • 1. Molecular docking, ADMET and molecular dynamics simulation revealed metralindole as a multitargeted inhibitor for division kinases.
    Al-Dhuayan I; ALaqeel NK
    Braz J Biol; 2023; 83():e271688. PubMed ID: 37075433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular docking analysis of mefluhybenamine with lung cancer targets.
    Alghamdi YS
    Bioinformation; 2022; 18(12):1186-1191. PubMed ID: 37701513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer.
    Binshaya AS; Alkahtani OS; Aldakheel FM; Hjazi A; Almasoudi HH
    Med Oncol; 2024 Mar; 41(5):101. PubMed ID: 38546811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multisampling-based docking reveals Imidazolidinyl urea as a multitargeted inhibitor for lung cancer: an optimisation followed multi-simulation and
    Ahmad S; Singh V; Gautam HK; Raza K
    J Biomol Struct Dyn; 2024 Mar; 42(5):2494-2511. PubMed ID: 37154501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of 5-nitroindazole as a multitargeted inhibitor for CDK and transferase kinase in lung cancer: a multisampling algorithm-based structural study.
    Ahmad S; Raza K
    Mol Divers; 2024 Jun; 28(3):1189-1202. PubMed ID: 37058176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variolin B from sea sponge against lung cancer: a multitargeted molecular docking with fingerprinting and molecular dynamics simulation study.
    Alsalmi O; Mashraqi MM; Alshamrani S; Almasoudi HH; Alharthi AA; Gharib AF
    J Biomol Struct Dyn; 2024 Apr; 42(7):3507-3519. PubMed ID: 37855303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural alkaloids targeting EGFR in non-small cell lung cancer: Molecular docking and ADMET predictions.
    Saini N; Grewal AS; Lather V; Gahlawat SK
    Chem Biol Interact; 2022 May; 358():109901. PubMed ID: 35341731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of luteolin -7-glucoside and epicatechin gallate from
    Maiti P; Nand M; Joshi T; Ramakrishnan MA; Chandra S
    J Biomol Struct Dyn; 2021 Sep; 39(14):5048-5057. PubMed ID: 32579072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular screening reveals Variolin B as a multitargeted inhibitor of lung cancer: a molecular docking-based fingerprinting and molecular dynamics simulation study.
    Almasoudi HH; Mashraqi MM; Alshamrani S; Alsalmi O; Alharthi AA; Gharib AF
    J Biomol Struct Dyn; 2024; 42(1):11-21. PubMed ID: 37771142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Computer - Aided Drug Designing for Pharmacological Inhibition of Mutant ALK for the Treatment of Non-small Cell Lung Cancer.
    Sharda S; Khandelwal R; Adhikary R; Sharma D; Majhi M; Hussain T; Nayarisseri A; Singh SK
    Curr Top Med Chem; 2019; 19(13):1129-1144. PubMed ID: 31109278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Insights into the Molecular Design of ROS1 Inhibitor for the Treatment of Non-Small Cell Lung Cancer (NSCLC).
    Adhikary R; Khandelwal R; Hussain T; Nayarisseri A; Singh SK
    Curr Comput Aided Drug Des; 2021; 17(3):387-401. PubMed ID: 32364080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unrevealing the multitargeted potency of 3-1-BCMIYPPA against lung cancer structural maintenance and suppression proteins through pharmacokinetics, QM-DFT, and multiscale MD simulation studies.
    Alshehri MA; Asiri SA; Helmi N; Baeissa HM; Hamadi A; Alzahrani A; Alghamdi RM; Rafeeq MM; Alharbi ZM; Kamal MA
    PLoS One; 2024; 19(6):e0303784. PubMed ID: 38905286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring natural compounds for the management of non-small cell lung cancer.
    S S; K R; V S
    Nat Prod Res; 2021 Dec; 35(24):5879-5882. PubMed ID: 32722994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
    Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Modeling, Docking, Dynamics and Simulation of Gefitinib and its Derivatives with EGFR in Non-small Cell Lung Cancer.
    Reddy PS; Lokhande KB; Nagar S; Reddy VD; Murthy PS; Swamy KV
    Curr Comput Aided Drug Des; 2018; 14(3):246-252. PubMed ID: 29493460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore based virtual screening, molecular docking and molecular dynamic simulation studies for finding ROS1 kinase inhibitors as potential drug molecules.
    Vanajothi R; Vedagiri H; Al-Ansari MM; Al-Humaid LA; Kumpati P
    J Biomol Struct Dyn; 2022 May; 40(8):3385-3399. PubMed ID: 33200682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An
    Malkaje S; Srinivasa MG; Deshpande N S; Navada S; Revanasiddappa Bc
    Curr Drug Res Rev; 2023; 15(1):88-100. PubMed ID: 36017854
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Thongsom S; Racha S; Ei ZZ; Petsri K; Aksorn N; Chamni S; Panpuang V; Zou H; Chanvorachote P
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based pharmacophore modeling, virtual screening and simulation studies for the identification of potent anticancerous phytochemical lead targeting cyclin-dependent kinase 2.
    Sharma M; Sharma N; Muddassir M; Rahman QI; Dwivedi UN; Akhtar S
    J Biomol Struct Dyn; 2022; 40(20):9815-9832. PubMed ID: 34151738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.